US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neumora Therapeutics, Inc.

0.7670

+0.00440.58%

Post-market: 0.77270.0057+0.74%19:56 EDT

Volume:651.41K

Turnover:494.12K

Market Cap:124.06M

PE:-0.50

High:0.7899

Open:0.7817

Low:0.7411

Close:0.7626

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), ImmunityBio (IBRX) and Exelixis (EXEL)

Galapagos CEO Paul Stoffels to Retire; Henry Gosebruch Named SpinCo Chief

MT Newswires Live

Galapagos Announces Executive Leadership Updates

Neumora Therapeutics Cut to Underperform From Buy by B of A Securities

Neumora Therapeutics Inc : Bofa Global Research Cuts to Underperform From Buy; Cuts Price Objective to $1 From $7

THOMSON REUTERS

Neumora Therapeutics, Inc. Faces Setbacks with Delayed MDD Program and Discontinued Bipolar Depression Study

Neumora Therapeutics downgraded to Underperform from Buy at BofA

William Blair Downgrades Neumora Therapeutics to Market Perform From Outperform

MT Newswires Live

Neumora Therapeutics downgraded to Market Perform from Outperform at William Blair

William Blair downgrades Neumora Therapeutics, Inc. (NMRA) to a Hold

BUZZ-U.S. STOCKS ON THE MOVE-Mobileye, Visionary Holdings, Wolfspeed

JNJ Halts Development of Depression Drug Over Efficacy Concerns

Neumora Therapeutics Shares Fall 13.8% After Johnson & Johnson Stops Studies of Rival Depression Drug

THOMSON REUTERS

BUZZ-Neumora falls as J&J's setback triggers concerns over depression drug

Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'

Neumora Therapeutics Shares Down 11.2% Premarket After Johnson & Johnson Stops Studies of Rival Depression Drug

THOMSON REUTERS

Neumora Therapeutics downgraded to Neutral from Buy at Guggenheim

BUZZ-Neumora's IPO bookrunner Stifel cuts to 'hold' after J&J setback

Stifel Downgrades Neumora Therapeutics to Hold From Buy, Adjusts Price Target to $2 From $6

MT Newswires Live

Neumora Therapeutics Inc : Stifel Cuts to Hold From Buy; Cuts Target Price to $2 From $6

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NMRA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":0.767,"timestamp":1745956800000,"preClose":0.7626,"halted":0,"volume":651407,"hourTrading":{"tag":"盘后","latestPrice":0.7727,"preClose":0.767,"latestTime":"19:56 EDT","volume":28542,"amount":21858.7826,"timestamp":1745970996380},"delay":0,"floatShares":53514397,"shares":161747922,"eps":-1.529624,"marketStatus":"Not Yet Opened","change":0.0044,"latestTime":"04-29 16:00:00 EDT","open":0.7817,"high":0.789899,"low":0.7411,"amount":494124.3238651,"amplitude":0.06399,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.529624,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746000000000},"marketStatusCode":0,"adr":0,"listingDate":1694750400000,"exchange":"NASDAQ","adjPreClose":0.7626,"preHourTrading":{"tag":"盘前","latestPrice":0.78,"preClose":0.7626,"latestTime":"09:18 EDT","volume":1381,"amount":1092.98548976,"timestamp":1745932687118},"postHourTrading":{"tag":"盘后","latestPrice":0.7727,"preClose":0.767,"latestTime":"19:56 EDT","volume":28542,"amount":21858.7826,"timestamp":1745970996380},"volumeRatio":0.632779,"impliedVol":0.8389,"impliedVolPercentile":0.34},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","floatShares":53514397,"roa":"-40.50%","roe":"-64.48%","lyrEps":-1.529624,"volumeRatio":0.632779,"shares":161747922,"dividePrice":0,"high":0.789899,"amplitude":0.06399,"preClose":0.7626,"low":0.7411,"week52Low":0.6211,"pbRate":"0.43","week52High":17.1874,"institutionHeld":0,"latestPrice":0.767,"eps":-1.529624,"divideRate":0,"volume":651407,"delay":0,"ttmEps":-1.529624,"open":0.7817,"prevYearClose":10.6,"prevWeekClose":0.7575,"prevMonthClose":1,"prevQuarterClose":1,"fiveDayClose":0.705,"twentyDayClose":1,"sixtyDayClose":1.93,"earningDate":1746979200000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMRA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531046231","title":"Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), ImmunityBio (IBRX) and Exelixis (EXEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2531046231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531046231?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:50","pubTimestamp":1745855457,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neumora Therapeutics, Inc. (NMRA – Research Report),...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neumora-therapeutics-inc-nmra-immunitybio-ibrx-and-exelixis-exel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neumora-therapeutics-inc-nmra-immunitybio-ibrx-and-exelixis-exel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRX","BK4139","NMRA","BK4137","BK4532","BK4007","HCSG","EXEL"],"gpt_icon":0},{"id":"2529235599","title":"Galapagos CEO Paul Stoffels to Retire; Henry Gosebruch Named SpinCo Chief","url":"https://stock-news.laohu8.com/highlight/detail?id=2529235599","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529235599?lang=en_us&edition=fundamental","pubTime":"2025-04-22 05:04","pubTimestamp":1745269497,"startTime":"0","endTime":"0","summary":"Galapagos  said Monday that CEO Paul Stoffels plans to retire upon the appointment of a successor within the next 12 months.The board appointed Henry Gosebruch as CEO of its XYZ SpinCo unit, which will separate from the company and be funded with about 2.45 billion euros  in cash and cash equivalents, Galapagos said.Gosebruch most recently served as CEO of Neumora , according to the company.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GLPG","BK4007","BK4139","NMRA"],"gpt_icon":0},{"id":"2529302053","title":"Galapagos Announces Executive Leadership Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2529302053","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529302053?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:10","pubTimestamp":1745266200,"startTime":"0","endTime":"0","summary":"Mr. Henry Gosebruch appointed by the Galapagos Board of Directors as founding CEO of newly created SpinCo. Mechelen, Belgium; April 21, 2025, 22:10 CET; regulated information – inside information – Galapagos NV , a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today makes two executive leadership announcements.Dr. Stoffels1, CEO and Chair of the Board of Directors at Galapagos, commented, “Henry’s appointment marks a key milestone as we progress on our planned Separation. His extensive biotech experience, leadership, and track record in creating shareholder value through M&A and business development will be of significant value to SpinCo, as it focuses on building a differentiated pipeline of innovative medicines with robust proof-of-concept.”Dr. Stoffels, Chair and CEO of Galapagos, has informed the Board of Directors of his intent to retire from his role as CEO upon appointment of a successor, and to remain as No","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/galapagos-announces-executive-leadership-updates-201000384.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4588","GLPG","BK4585","BK4156","IPO","NMRA","STRK","BK4596","BK4595","EU","BK4516","BK4600","BK4023","BK4139"],"gpt_icon":1},{"id":"2524498780","title":"Neumora Therapeutics Cut to Underperform From Buy by B of A Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2524498780","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524498780?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:39","pubTimestamp":1743597540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NMRA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 02, 2025 08:39 ET (12:39 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","NMRA"],"gpt_icon":0},{"id":"2524030466","title":"Neumora Therapeutics Inc : Bofa Global Research Cuts to Underperform From Buy; Cuts Price Objective to $1 From $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2524030466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524030466?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:07","pubTimestamp":1743592077,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QG0VH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"gpt_icon":0},{"id":"2524145174","title":"Neumora Therapeutics, Inc. Faces Setbacks with Delayed MDD Program and Discontinued Bipolar Depression Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2524145174","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524145174?lang=en_us&edition=fundamental","pubTime":"2025-04-02 17:05","pubTimestamp":1743584724,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics, Inc. (NMRA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tazee...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/neumora-therapeutics-inc-faces-setbacks-with-delayed-mdd-program-and-discontinued-bipolar-depression-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/neumora-therapeutics-inc-faces-setbacks-with-delayed-mdd-program-and-discontinued-bipolar-depression-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVC","BK4007","BK4139","NMRA"],"gpt_icon":0},{"id":"2524108456","title":"Neumora Therapeutics downgraded to Underperform from Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2524108456","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524108456?lang=en_us&edition=fundamental","pubTime":"2025-04-02 16:55","pubTimestamp":1743584128,"startTime":"0","endTime":"0","summary":"BofA double downgraded Neumora Therapeutics (NMRA) to Underperform from Buy with a price target of $1, down from $7. The firm is taking a more cons...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-underperform-from-buy-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-underperform-from-buy-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","LENZ"],"gpt_icon":0},{"id":"2518733247","title":"William Blair Downgrades Neumora Therapeutics to Market Perform From Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2518733247","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518733247?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:37","pubTimestamp":1741606627,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics (NMRA) has an average rating of overweight and mean price target of $6.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NMRA","LENZ"],"gpt_icon":0},{"id":"2517746163","title":"Neumora Therapeutics downgraded to Market Perform from Outperform at William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2517746163","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517746163?lang=en_us&edition=fundamental","pubTime":"2025-03-08 06:06","pubTimestamp":1741385178,"startTime":"0","endTime":"0","summary":"William Blair downgraded Neumora Therapeutics (NMRA) to Market Perform from Outperform. Published first on TheFly – the ultimate source for real-ti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-market-perform-from-outperform-at-william-blair?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-market-perform-from-outperform-at-william-blair?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","NMRA"],"gpt_icon":0},{"id":"2517469605","title":"William Blair downgrades Neumora Therapeutics, Inc. (NMRA) to a Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2517469605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517469605?lang=en_us&edition=fundamental","pubTime":"2025-03-08 05:26","pubTimestamp":1741382778,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics, Inc. (NMRA – Research Report) received a Hold rating and price target from William Blair analyst Myles Minter today. Accordin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-downgrades-neumora-therapeutics-inc-nmra-to-a-hold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-downgrades-neumora-therapeutics-inc-nmra-to-a-hold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA"],"gpt_icon":0},{"id":"2517454561","title":"BUZZ-U.S. STOCKS ON THE MOVE-Mobileye, Visionary Holdings, Wolfspeed","url":"https://stock-news.laohu8.com/highlight/detail?id=2517454561","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517454561?lang=en_us&edition=fundamental","pubTime":"2025-03-08 02:52","pubTimestamp":1741373564,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Mobileye, Visionary Holdings, WolfspeedEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsle","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL3N3PQ1AL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","W","NFE","IE00BMCWC346.EUR","CVX","LU0170899867.USD","CHRW","LU1883839398.USD","LU2471134523.USD","GAP","NEM","WBA","COO","LU0368265764.SGD","KLXE","LU2552382132.HKD","HAL","PBPB","BK4512","GM","LE","BHVN","AFBI","VEL","MBLY","WOLF","CRMD","LU1732800096.USD","WMB","LU0006061336.USD","LU0068578508.USD","LU0708994859.HKD","SG9999015945.SGD","NMRA","BK4559","XOM","COOK","MLNK","F","JBHT","IOT","HPE","LU2361044865.SGD","ODFL","BK4138","JAZZ"],"gpt_icon":1},{"id":"2517538457","title":"JNJ Halts Development of Depression Drug Over Efficacy Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2517538457","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517538457?lang=en_us&edition=fundamental","pubTime":"2025-03-08 01:45","pubTimestamp":1741369500,"startTime":"0","endTime":"0","summary":"Johnson & Johnson JNJ decided to discontinue the Phase 3 VENTURA development program, which is evaluating aticaprant as an adjunctive treatment for major depressive disorder .Though data from the VENTURA program did confirm that the J&J drug was safe and well-tolerated in study participants, the decision to stop developing it for MDD indication is due to ‘insufficient efficacy in the target patient population.’ However, the pharma giant still intends to explore aticaprant’s potential ‘in other areas of high unmet need.’。J&J is currently undergoing full analyses of data from the VENTURA program and intends to share the same at a future medical meeting.This comes as a setback to J&J, which had high expectations for aticaprant in the MDD indication. The company has forecasted generating annual peak sales in the range of $1-$5 billion from the drug in the now-abandoned indication.J&J Reiterates Long-Term View for Innovative Medicine Biz","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jnj-halts-development-depression-drug-174500525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z3B42.SGD","LU0122379950.USD","JNJ","IE00BJJMRZ35.SGD","ABVC","NMRA","LU0234570918.USD","LU1732800096.USD","LU2602419157.SGD","LU1066051225.USD","LU2505996681.GBP","LU0289739699.SGD","BK4533","LU0345769631.USD","LU0234572021.USD","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","IE00BDGV0183.EUR","LU1061106388.HKD","LU1059921491.USD","LU2129689514.USD","LU2430703178.SGD","IE00B19Z3581.USD","LU1066051498.USD","LU1267930813.SGD","BK4532","IE00B2B36J28.USD","LU1057294990.SGD","SG9999001440.SGD","IE00B1BXHZ80.USD","LU0912757837.SGD","LU1261432733.SGD","LU1732799900.SGD","BK4581","IE00BGHQF631.EUR","IE00BSNM7G36.USD","IE00BVYPNV92.GBP","LU0058720904.USD","LU0098860793.USD","LU0795875086.SGD","LU2468319806.SGD","ITCI","SG9999002224.SGD","LU0792757196.USD","IE0002270589.USD","LU2112291526.USD","IE0002141913.USD","LU1674673691.USD","IE00BFTCPJ56.SGD","LU0889566641.SGD"],"gpt_icon":0},{"id":"2517439580","title":"Neumora Therapeutics Shares Fall 13.8% After Johnson & Johnson Stops Studies of Rival Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2517439580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517439580?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:30","pubTimestamp":1741357858,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0GA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2129689514.USD","LU1430594728.SGD","LU1894683348.USD","LU0795875169.SGD","LU2505996509.AUD","LU1221951129.SGD","IE00B4R5TH58.HKD","BK4559","LU2129689431.USD","LU2089984988.USD","LU1267930813.SGD","BK4568","LU0882574055.USD","LU1057294990.SGD","LU0795875086.SGD","NMRA","LU0345770993.USD","LU2468319806.SGD","LU0345769631.USD","LU1244550577.SGD","IE0002270589.USD","LU1032466523.USD","LU1506573853.SGD","LU0114720955.EUR","JNJ","LU2430703095.HKD","LU1718418525.SGD","LU0912757837.SGD","LU1280957306.USD","LU1059921491.USD","LU0122379950.USD","SG9999002224.SGD","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","LU0320765646.SGD","SG9999002232.USD","BK4532","LU1732800096.USD","IE00BJJMRZ35.SGD","BK4504","IE00B1BXHZ80.USD","IE0002141913.USD","LU1244550494.USD","BK4534","LU1066051811.HKD","IE00BVYPNV92.GBP","IE00BSNM7G36.USD","IE00B3PB1722.GBP","LU1066053197.SGD","LU1935042991.SGD"],"gpt_icon":0},{"id":"2517743572","title":"BUZZ-Neumora falls as J&J's setback triggers concerns over depression drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2517743572","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517743572?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:11","pubTimestamp":1741356694,"startTime":"0","endTime":"0","summary":"BUZZ-Neumora falls as J&J's setback triggers concerns over depression drug Updates** Shares of Neumora Therapeutics NMRA.O fall 11.2% to $1.35 premarket, set to break three-day winning streak","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL3N3PQ17A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","BK4581","LU1732800096.USD","LU0203345920.USD","LU1162221912.USD","LU0114720955.EUR","IE00B3PB1722.GBP","NMRA","JNJ","LU0058720904.USD","LU2430703095.HKD","LU1032466523.USD","LU1057294990.SGD","LU1066053197.SGD","LU2430703178.SGD","BK4532","IE00B42XCP33.USD","LU0234570918.USD","LU1430594728.SGD","LU1674673428.USD","LU2430703251.USD","BK4585","LU1506573853.SGD","LU0098860793.USD","LU1894683348.USD","LU2112291526.USD","LU1221951046.USD","BK4534","BK4592","LU1061106388.HKD","BK4533","LU0795875086.SGD","LU1244550221.USD","LU1732799900.SGD","IE00BVYPNV92.GBP","IE00BJJMRZ35.SGD","SF","LU0203347892.USD","LU1244550494.USD","BK4588","LU0640476718.USD","IE0009355771.USD","LU0345769128.USD","BK4127","LU0122379950.USD","LU1585245621.USD","BK4504","LU1066051498.USD","LU2505996509.AUD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2517243109","title":"Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'","url":"https://stock-news.laohu8.com/highlight/detail?id=2517243109","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517243109?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:03","pubTimestamp":1741356230,"startTime":"0","endTime":"0","summary":"On Friday, Johnson & Johnson  decided to discontinue the Phase 3 VENTURA development program evaluating aticaprant, a kappa opioid receptor  antagonist, as an adjunctive treatment for major depressive disorder .The move follows insufficient efficacy in the target patient population. The data confirmed aticaprant is safe and well-tolerated, and no new safety signals were identified.In January, Neumora Therapeutics, Inc.’s released data from the Phase 3 KOASTAL-1 Study of navacaprant for major depressive disorder.The study did not demonstrate a statistically significant improvement on the primary endpoint of change from baseline in the Montgomery-sberg Depression Rating Scale  total score at Week 6 or the key secondary endpoint of a change from baseline in the Snaith-Hamilton Pleasure Scale  scale.Navacaprant, like aticaprant, is a kappa opioid receptor antagonist. Johnson & Johnsonsays it continues to build on its leadership in Neuroscience.In January, the healthcare giant agreed to acq","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-stops-stage-depression-140350234.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NMRA","LU0640476718.USD","LU2129689605.HKD","LU2089984988.USD","LU2347655156.SGD","IE00B7SZLL34.SGD","ITCI","IE00BDGV0183.EUR","LU1066053197.SGD","LU2129689514.USD","SG9999001440.SGD","IE00B4R5TH58.HKD","IE00BVYPNW00.USD","LU1023059063.AUD","LU2592432038.USD","LU0345769128.USD","LU0795875086.SGD","LU0889566641.SGD","BK4504","BK4568","LU1057294990.SGD","LU1244550221.USD","LU1032955483.USD","IE00BFTCPJ56.SGD","LU1221951129.SGD","LU0012050646.USD","LU1059921491.USD","LU2129689431.USD","LU1778281490.HKD","LU0882574055.USD","LU1585245621.USD","LU0203347892.USD","LU0234570918.USD","SSI","IE0034235303.USD","LU0114720955.EUR","LU2505996509.AUD","IE0002270589.USD","BK4007","IE000M9KFDE8.USD","BK4534","BK4588","LU0109394709.USD","LU0203345920.USD","SG9999002232.USD","IE0002141913.USD","LU1674673428.USD","JNJ","LU0058720904.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2517433745","title":"Neumora Therapeutics Shares Down 11.2% Premarket After Johnson & Johnson Stops Studies of Rival Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2517433745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517433745?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:58","pubTimestamp":1741355935,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0G2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0466842654.USD","SG9999001440.SGD","LU0345769631.USD","LU0289739699.SGD","LU1244550494.USD","LU0345770308.USD","IE00BFTCPJ56.SGD","BK4559","LU1074936037.SGD","LU1066051225.USD","IE00B2B36J28.USD","LU1061106388.HKD","SG9999002232.USD","BK4568","JNJ","LU1914381329.SGD","IE00B4R5TH58.HKD","IE00B1BXHZ80.USD","LU1023059063.AUD","BK4007","IE00BVYPNW00.USD","LU0058720904.USD","LU0792757196.USD","IE0002270589.USD","LU2112291526.USD","LU1244550221.USD","LU0114720955.EUR","IE00B7SZLL34.SGD","SG9999002224.SGD","LU1506573853.SGD","LU1585245621.USD","LU0203347892.USD","LU1280957306.USD","LU0203345920.USD","IE00BSNM7G36.USD","LU0345770993.USD","LU1066053197.SGD","IE00B42XCP33.USD","LU0882574055.USD","LU1894683264.USD","IE00B3PB1722.GBP","LU1929549753.HKD","LU1162221912.USD","LU1196500208.SGD","LU1732799900.SGD","LU1032466523.USD","LU2129689431.USD","NMRA","IE00B19Z3B42.SGD","BK4550"],"gpt_icon":0},{"id":"2517480075","title":"Neumora Therapeutics downgraded to Neutral from Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2517480075","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517480075?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:01","pubTimestamp":1741352518,"startTime":"0","endTime":"0","summary":"Guggenheim downgraded Neumora Therapeutics (NMRA) to Neutral from Buy. with no price target following yesterday’s announcement that Johnson & Johns...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-neutral-from-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-neutral-from-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","NMRA"],"gpt_icon":0},{"id":"2517648768","title":"BUZZ-Neumora's IPO bookrunner Stifel cuts to 'hold' after J&J setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2517648768","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517648768?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:55","pubTimestamp":1741352129,"startTime":"0","endTime":"0","summary":"BUZZ-Neumora's IPO bookrunner Stifel cuts to 'hold' after J&J setback ** Brokerage Stifel cuts rating on Neumora Therapeutics NMRA.O to \"hold\" from \"buy\" after Johnson & Johnson JNJ.N scrapped trials ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL3N3PQ11Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2592432038.USD","LU0289739699.SGD","LU2505996509.AUD","LU1061106388.HKD","LU0345770308.USD","BK4007","LU0889566641.SGD","LU1244550577.SGD","LU1674673428.USD","LU1244550221.USD","LU0203345920.USD","LU1778281490.HKD","LU0466842654.USD","LU0098860793.USD","LU1066053197.SGD","BK4592","LU1430594728.SGD","IE0002141913.USD","IE00BVYPNV92.GBP","LU0122379950.USD","LU0234572021.USD","IE00B2B36J28.USD","LU0792757196.USD","BK4588","LU1929549753.HKD","LU1674673691.USD","IE0009355771.USD","IE0034235303.USD","IE00B19Z3B42.SGD","LU1732799900.SGD","IE00B19Z3581.USD","LU0882574055.USD","LU1032466523.USD","SG9999002224.SGD","IE0002270589.USD","JNJ","LU1267930813.SGD","IE00BGHQF631.EUR","LU1261432733.SGD","IE00B42XCP33.USD","LU2430703251.USD","NMRA","LU0320765646.SGD","LU1221951129.SGD","LU1914381329.SGD","LU2505996681.GBP","BK4550","IE00B3PB1722.GBP","LU1280957306.USD","LU1023059063.AUD"],"gpt_icon":0},{"id":"2517484901","title":"Stifel Downgrades Neumora Therapeutics to Hold From Buy, Adjusts Price Target to $2 From $6","url":"https://stock-news.laohu8.com/highlight/detail?id=2517484901","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517484901?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:26","pubTimestamp":1741350386,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics (NMRA) has an average rating of overweight and mean price target of $6.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NMRA","LENZ","SF"],"gpt_icon":0},{"id":"2517548196","title":"Neumora Therapeutics Inc : Stifel Cuts to Hold From Buy; Cuts Target Price to $2 From $6","url":"https://stock-news.laohu8.com/highlight/detail?id=2517548196","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517548196?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:08","pubTimestamp":1741349287,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":115,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMRA\",params:#limit:5,,,undefined,":[{"date":"2025-05-12","symbol":"NMRA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.4,"defaultRemindTime":1747080000000,"name":null,"time":"Post Market","dateTimestamp":1747022400000,"actualEps":null},{"market":"US","date":"2024-11-12","symbol":"NMRA","fiscalQuarterEnding":"2024/09","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.5556,"sell":0.1111,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5556,"analysts":9,"updateTime":1743566400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NMRA","date":"2025-04-28","current":-0.502586,"percent":0.962865,"low":-19.620035,"twenty":-12.285927,"median":-6.901823,"eighty":-1.344426,"high":-0.41859,"avg":-7.904432,"sd":5.013584,"marketCap":122524050},"quantilePoints":[{"date":"2023-09-15","current":-19.620035,"twenty":-19.620035,"median":-19.620035,"eighty":-19.620035,"marketCap":2583134632},{"date":"2023-09-22","current":-12.753675,"twenty":-18.754446,"median":-15.453663,"eighty":-12.753675,"marketCap":1679123396},{"date":"2023-09-28","current":-13.691957,"twenty":-17.415667,"median":-13.628246,"eighty":-12.772209,"marketCap":1802655635},{"date":"2023-10-05","current":-13.813351,"twenty":-16.65135,"median":-13.723658,"eighty":-12.773914,"marketCap":1818638110},{"date":"2023-10-13","current":-11.180579,"twenty":-14.994038,"median":-13.691957,"eighty":-12.763183,"marketCap":1472012710},{"date":"2023-10-20","current":-11.493728,"twenty":-13.94093,"median":-13.080265,"eighty":-11.639864,"marketCap":1513241282},{"date":"2023-10-27","current":-14.254079,"twenty":-14.080107,"median":-13.080265,"eighty":-11.690896,"marketCap":1876663508},{"date":"2023-11-03","current":-10.734234,"twenty":-13.848145,"median":-12.776843,"eighty":-11.493728,"marketCap":1667466680},{"date":"2023-11-10","current":-10.420012,"twenty":-13.826354,"median":-12.7442,"eighty":-11.403032,"marketCap":1618655149},{"date":"2023-11-17","current":-11.79624,"twenty":-13.813351,"median":-12.154821,"eighty":-11.403032,"marketCap":1832439792},{"date":"2023-11-24","current":-11.717599,"twenty":-13.766958,"median":-11.806071,"eighty":-11.438475,"marketCap":1820223526},{"date":"2023-12-01","current":-12.041995,"twenty":-13.704638,"median":-11.815901,"eighty":-11.48267,"marketCap":1870615621},{"date":"2023-12-08","current":-12.26809,"twenty":-13.59002,"median":-11.825731,"eighty":-11.493283,"marketCap":1905737383},{"date":"2023-12-15","current":-14.381583,"twenty":-13.717318,"median":-11.894542,"eighty":-11.493728,"marketCap":2234049513},{"date":"2023-12-22","current":-13.75245,"twenty":-13.821153,"median":-12.041995,"eighty":-11.521564,"marketCap":2136319390},{"date":"2023-12-29","current":-16.848963,"twenty":-14.008036,"median":-12.137729,"eighty":-11.563317,"marketCap":2617334836},{"date":"2024-01-05","current":-16.111698,"twenty":-14.24211,"median":-12.26809,"eighty":-11.573312,"marketCap":2502807349},{"date":"2024-01-12","current":-14.991056,"twenty":-14.660761,"median":-12.728927,"eighty":-11.585874,"marketCap":2328725569},{"date":"2024-01-19","current":-14.411074,"twenty":-14.428768,"median":-12.751722,"eighty":-11.613398,"marketCap":2238630612},{"date":"2024-01-26","current":-14.843603,"twenty":-15.020547,"median":-12.776843,"eighty":-11.648787,"marketCap":2305820071},{"date":"2024-02-02","current":-14.991056,"twenty":-15.264335,"median":-13.370218,"eighty":-11.652719,"marketCap":2328725569},{"date":"2024-02-09","current":-17.1537,"twenty":-15.346909,"median":-13.691957,"eighty":-11.671529,"marketCap":2664672864},{"date":"2024-02-16","current":-18.490607,"twenty":-15.539581,"median":-13.783396,"eighty":-11.691031,"marketCap":2872349373},{"date":"2024-02-23","current":-18.500437,"twenty":-15.932789,"median":-13.819852,"eighty":-11.69454,"marketCap":2873876407},{"date":"2024-03-01","current":-17.330643,"twenty":-16.668088,"median":-13.939224,"eighty":-11.709735,"marketCap":2692159461},{"date":"2024-03-08","current":-12.297819,"twenty":-16.990518,"median":-13.97363,"eighty":-11.717599,"marketCap":2901363004},{"date":"2024-03-15","current":-10.189453,"twenty":-16.81554,"median":-13.826354,"eighty":-11.69454,"marketCap":2403946708},{"date":"2024-03-22","current":-9.414974,"twenty":-16.668088,"median":-13.783396,"eighty":-11.650753,"marketCap":2221227691},{"date":"2024-03-28","current":-8.492333,"twenty":-16.613039,"median":-13.722203,"eighty":-11.579976,"marketCap":2003553733},{"date":"2024-04-05","current":-9.246609,"twenty":-16.364935,"median":-13.534996,"eighty":-11.491504,"marketCap":2181506166},{"date":"2024-04-12","current":-9.435178,"twenty":-16.111698,"median":-12.865966,"eighty":-11.216259,"marketCap":2225994275},{"date":"2024-04-19","current":-7.105005,"twenty":-15.954415,"median":-12.753675,"eighty":-10.606446,"marketCap":1676248365},{"date":"2024-04-26","current":-6.123304,"twenty":-15.846283,"median":-12.728927,"eighty":-10.162515,"marketCap":1444640411},{"date":"2024-05-03","current":-6.231441,"twenty":-15.669339,"median":-12.297819,"eighty":-9.792112,"marketCap":1470152824},{"date":"2024-05-10","current":-6.135514,"twenty":-15.610358,"median":-12.155389,"eighty":-9.435178,"marketCap":1558549450},{"date":"2024-05-17","current":-6.047595,"twenty":-15.433415,"median":-12.120637,"eighty":-9.273547,"marketCap":1536216091},{"date":"2024-05-24","current":-5.846636,"twenty":-15.423584,"median":-11.91675,"eighty":-8.957021,"marketCap":1485168412},{"date":"2024-05-31","current":-6.085275,"twenty":-15.399992,"median":-11.884712,"eighty":-8.469435,"marketCap":1545787530},{"date":"2024-06-07","current":-6.235993,"twenty":-15.362637,"median":-11.806071,"eighty":-7.09423,"marketCap":1584073290},{"date":"2024-06-14","current":-6.248553,"twenty":-15.342977,"median":-11.75692,"eighty":-6.904314,"marketCap":1587263770},{"date":"2024-06-21","current":-5.557759,"twenty":-15.335113,"median":-11.717599,"eighty":-6.419582,"marketCap":1411787373},{"date":"2024-06-28","current":-5.777557,"twenty":-15.335113,"median":-11.707769,"eighty":-6.279953,"marketCap":1467620772},{"date":"2024-07-05","current":-6.129234,"twenty":-15.228947,"median":-11.690896,"eighty":-6.264891,"marketCap":1556954210},{"date":"2024-07-12","current":-7.253346,"twenty":-15.12278,"median":-11.653703,"eighty":-6.277441,"marketCap":1842502165},{"date":"2024-07-15","current":-6.939348,"twenty":-15.110984,"median":-11.648787,"eighty":-6.278697,"marketCap":1762740166},{"date":"2024-08-02","current":-7.931581,"twenty":-15.099188,"median":-11.648787,"eighty":-6.279953,"marketCap":2014788082},{"date":"2024-08-09","current":-6.56038,"twenty":-15.040207,"median":-11.579976,"eighty":-6.279953,"marketCap":1798711865},{"date":"2024-08-16","current":-6.881395,"twenty":-14.991056,"median":-11.493728,"eighty":-6.279953,"marketCap":1886727125},{"date":"2024-08-23","current":-6.712133,"twenty":-14.991056,"median":-11.447336,"eighty":-6.393648,"marketCap":1840319079},{"date":"2024-08-30","current":-6.54287,"twenty":-14.922244,"median":-11.299816,"eighty":-6.436952,"marketCap":1793911032},{"date":"2024-09-06","current":-6.297731,"twenty":-14.859331,"median":-10.957407,"eighty":-6.374465,"marketCap":1726699379},{"date":"2024-09-13","current":-6.904742,"twenty":-14.68632,"median":-10.606446,"eighty":-6.374465,"marketCap":1893128235},{"date":"2024-09-20","current":-7.430039,"twenty":-14.481851,"median":-10.304733,"eighty":-6.410301,"marketCap":2037153206},{"date":"2024-09-27","current":-7.634321,"twenty":-14.416972,"median":-9.973946,"eighty":-6.432454,"marketCap":2093162917},{"date":"2024-10-04","current":-7.905725,"twenty":-14.387481,"median":-9.835887,"eighty":-6.454177,"marketCap":2167575819},{"date":"2024-10-11","current":-8.988421,"twenty":-14.365855,"median":-9.536197,"eighty":-6.471402,"marketCap":2464427288},{"date":"2024-10-18","current":-9.898936,"twenty":-14.275648,"median":-9.492422,"eighty":-6.494727,"marketCap":2714070572},{"date":"2024-10-25","current":-7.587628,"twenty":-14.23812,"median":-9.435178,"eighty":-6.5109,"marketCap":2080360698},{"date":"2024-10-31","current":-7.126534,"twenty":-14.186945,"median":-9.414974,"eighty":-6.517189,"marketCap":1953938778},{"date":"2024-11-08","current":-7.599301,"twenty":-14.11026,"median":-9.329429,"eighty":-6.519524,"marketCap":2083561252},{"date":"2024-11-15","current":-6.430581,"twenty":-14.036864,"median":-9.246609,"eighty":-6.508113,"marketCap":1888648838},{"date":"2024-11-22","current":-5.330396,"twenty":-14.008036,"median":-9.078889,"eighty":-6.434404,"marketCap":1565526710},{"date":"2024-11-29","current":-5.467919,"twenty":-13.980511,"median":-8.972721,"eighty":-6.336098,"marketCap":1605916976},{"date":"2024-12-06","current":-5.313893,"twenty":-13.902792,"median":-8.614876,"eighty":-6.276185,"marketCap":1560679878},{"date":"2024-12-13","current":-5.819979,"twenty":-13.839429,"median":-8.495238,"eighty":-6.248553,"marketCap":1709316057},{"date":"2024-12-20","current":-5.775971,"twenty":-13.821153,"median":-8.377845,"eighty":-6.222869,"marketCap":1696391172},{"date":"2024-12-27","current":-6.238049,"twenty":-13.812967,"median":-8.200475,"eighty":-6.175381,"marketCap":1832102465},{"date":"2025-01-03","current":-1.083682,"twenty":-13.811432,"median":-8.147945,"eighty":-6.157876,"marketCap":318275296},{"date":"2025-01-10","current":-1.303719,"twenty":-13.766574,"median":-7.931581,"eighty":-6.140538,"marketCap":382899721},{"date":"2025-01-17","current":-1.193701,"twenty":-13.753032,"median":-7.891133,"eighty":-6.119668,"marketCap":350587508},{"date":"2025-01-24","current":-1.1882,"twenty":-13.716154,"median":-7.812392,"eighty":-6.085275,"marketCap":348971898},{"date":"2025-01-31","current":-1.056178,"twenty":-13.615504,"median":-7.634321,"eighty":-6.067691,"marketCap":310197242},{"date":"2025-02-07","current":-1.07268,"twenty":-13.546812,"median":-7.564281,"eighty":-5.978405,"marketCap":315044074},{"date":"2025-02-14","current":-0.929656,"twenty":-13.337262,"median":-7.53602,"eighty":-5.966304,"marketCap":273038198},{"date":"2025-02-21","current":-0.940658,"twenty":-13.1053,"median":-7.470895,"eighty":-5.920328,"marketCap":276269419},{"date":"2025-02-28","current":-0.852643,"twenty":-12.883791,"median":-7.424202,"eighty":-5.847483,"marketCap":250419649},{"date":"2025-03-07","current":-1.009931,"twenty":-12.773914,"median":-7.253346,"eighty":-5.800175,"marketCap":246207962},{"date":"2025-03-14","current":-0.930199,"twenty":-12.763183,"median":-7.144044,"eighty":-5.763741,"marketCap":226770492},{"date":"2025-03-21","current":-0.770737,"twenty":-12.752113,"median":-7.105005,"eighty":-5.687956,"marketCap":187895550},{"date":"2025-03-28","current":-0.730871,"twenty":-12.743752,"median":-7.036301,"eighty":-5.574632,"marketCap":178176815},{"date":"2025-04-04","current":-0.564099,"twenty":-12.730087,"median":-6.998128,"eighty":-5.417311,"marketCap":137520105},{"date":"2025-04-11","current":-0.476129,"twenty":-12.580434,"median":-6.945391,"eighty":-5.374404,"marketCap":116074096},{"date":"2025-04-17","current":-0.41859,"twenty":-12.352677,"median":-6.926527,"eighty":-5.321594,"marketCap":102046721},{"date":"2025-04-25","current":-0.497989,"twenty":-12.291873,"median":-6.904742,"eighty":-1.375231,"marketCap":121403202},{"date":"2025-04-28","current":-0.502586,"twenty":-12.285927,"median":-6.901823,"eighty":-1.344426,"marketCap":122524050}],"updateTime":1745973525150}}}